John Cunningham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John Cunningham has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Jorge Benito Cannata-Andía
Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS2040, Kidney Disease), 28040 Madrid, Spain
2 shared publications - Pieter Evenepoel
Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, Katholieke Universiteit Leuven , Leuven
2 shared publications - Serge Ferrari
Division of Bone Diseases, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva , Geneva
2 shared publications - Aldo Scarpa
ARC-NET Research Centre, University of Verona, Verona, Italy
1 shared publication - Andrea Aghi
Clinica Medica 1, Department of Medicine, University of Padova, 35128 Padova, Italy
1 shared publication - Andrea Trombetti
Division of Geriatrics, Department of Rehabilitation and Geriatrics, Geneva University Hospitals and Faculty of Medicine, Thônex, Switzerland
1 shared publication
Latest Publications
- Open Access
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism
Bone Biopsy (BB) with histomorphometric analysis still represents the gold standard for the diagnosis and classification of different forms of renal osteodystrophy. Bone biopsy is the only technique able to provide comprehensive information on all bone parameters, measuring static and dynamic parameters of turnover, cortical and trabecular microarchitecture, and mineralization defects. In nephrological practice, bone biopsy yields relevant indications to support therapeutic choices in CKD, heavily impacting the management and prognosis of uremic patients. Unfortunately, the use of bone biopsy has decreased; a lack of expertise in performing and interpreting, perceived procedure invasiveness and pain, and reimbursement issues have all contributed to this decline. Nevertheless, both bone biomarkers and instrumental images cannot be considered reliable surrogates for histological findings, being insufficiently accurate to properly evaluate underlying mineral and bone disorders. This is a multidisciplinary position paper from the Nephrology and Osteoporosis Italian Scientific Societies with the purpose of restating the role of bone biopsy in CKD patient management and of providing strong solutions to allow diffusion of this technique in Italy, but potentially also in other countries. The Italian approach through the optimization and standardization of bone biopsy procedure, the construction of the Italian Hub and Spoke network, and a request for adjustment and national homogenization of reimbursement to the Italian Health Ministry has led the way to implement bone biopsy and to improve CKD patient management and prognosis.
Open AccessTime for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism
Bone Biopsy (BB) with histomorphometric analysis still represents the gold standard for the diagnosis and classification of different forms of renal osteodystrophy. Bone biopsy is the only technique able to provide comprehensive information on all bone parameters, measuring static and dynamic parameters of turnover, cortical and trabecular microarchitecture, and mineralization defects. In nephrological practice, bone biopsy yields relevant indications to support therapeutic choices in CKD, heavily impacting the management and prognosis of uremic patients. Unfortunately, the use of bone biopsy has decreased; a lack of expertise in performing and interpreting, perceived procedure invasiveness and pain, and reimbursement issues have all contributed to this decline. Nevertheless, both bone biomarkers and instrumental images cannot be considered reliable surrogates for histological findings, being insufficiently accurate to properly evaluate underlying mineral and bone disorders. This is a multidisciplinary position paper from the Nephrology and Osteoporosis Italian Scientific Societies with the purpose of restating the role of bone biopsy in CKD patient management and of providing strong solutions to allow diffusion of this technique in Italy, but potentially also in other countries. The Italian approach through the optimization and standardization of bone biopsy procedure, the construction of the Italian Hub and Spoke network, and a request for adjustment and national homogenization of reimbursement to the Italian Health Ministry has led the way to implement bone biopsy and to improve CKD patient management and prognosis.
- 15 June 2021
- Published by Springer Nature in Osteoporosis International
- Vol. 32 (12) , 2397-2405
Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism
The European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) CKD-MBD working group, in collaboration with the Committee of Scientific Advisors of the International Osteoporosis Foundation, published a position paper for the diagnosis and management of osteoporosis in patients with CKD stages 4–5D (eGFR < 30 ml/min 1.73 m2). The present article reports and summarizes the main recommendations included in this 2021 document. The following areas are reviewed: diagnosis of osteoporosis; risk factors for fragility fractures; fracture risk assessment; intervention thresholds for pharmacological intervention; general and pharmacological management of osteoporosis; monitoring of treatment, and systems of care, all in patients with CKD stages 4–5D. Guidance is provided for clinicians caring for CKD stages 4–5D patients with osteoporosis, allowing for a pragmatic individualized diagnostic and therapeutic approach as an alternative to current variations in care and treatment nihilism.
- 15 June 2021
- Published by Springer Nature in Osteoporosis International
- Vol. 32 (12) , 2397-2405
Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism
The European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) CKD-MBD working group, in collaboration with the Committee of Scientific Advisors of the International Osteoporosis Foundation, published a position paper for the diagnosis and management of osteoporosis in patients with CKD stages 4–5D (eGFR < 30 ml/min 1.73 m2). The present article reports and summarizes the main recommendations included in this 2021 document. The following areas are reviewed: diagnosis of osteoporosis; risk factors for fragility fractures; fracture risk assessment; intervention thresholds for pharmacological intervention; general and pharmacological management of osteoporosis; monitoring of treatment, and systems of care, all in patients with CKD stages 4–5D. Guidance is provided for clinicians caring for CKD stages 4–5D patients with osteoporosis, allowing for a pragmatic individualized diagnostic and therapeutic approach as an alternative to current variations in care and treatment nihilism.
- Open Access
- 1 July 2019
- Published by Elsevier in Kidney International Reports
- Vol. 4 (7) , 987-994
Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
- 1 July 2019
- Published by Elsevier in Kidney International Reports
- Vol. 4 (7) , 987-994
Open AccessEtelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
- 22 September 2016
- Published by Springer Nature
- p. 405-420
Vitamin D and Mortality Risk in Chronic Kidney Disease
- 22 September 2016
- Published by Springer Nature
- p. 405-420
Vitamin D and Mortality Risk in Chronic Kidney Disease
- Open Access
- 11 March 2015
- Published by South African Medical Association NPC in South African Medical Journal
- Vol. 105 (4) , 253
Stephen Hough
- 11 March 2015
- Published by South African Medical Association NPC in South African Medical Journal
- Vol. 105 (4) , 253
Open AccessStephen Hough
- 1 March 2014
- Published by Springer Nature
- p. 581-587
Chronic Kidney Disease: Mineral and Bone Disorder (CKD-MBD)
- 1 March 2014
- Published by Springer Nature
- p. 581-587
Chronic Kidney Disease: Mineral and Bone Disorder (CKD-MBD)
- Open Access
- 5 May 2011
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 26 (6) , 1764-1766
CKD-MBD: comfort in the trough of the U
Two large historical cohort studies, Control of Renal Osteodystrophy in South America (CORES) and Analyzing Data, Recognizing Excellence and Optimizing Outcome (ARO), are published in this issue of Nephrology Dialysis Transplantation. Both describe associations between biochemical measures of chronic kidney disease–mineral bone disease (CKD–MBD) which add usefully to the body of evidence already published in this and related fields. Hitherto, studies of this type have, with the exception of those derived from the Dialysis Outcomes and Practice Patterns (DOPPS) study, reflected data acquired from large US-based populations receiving maintenance dialysis. In contrast, the studies under discussion here have utilized patient groups with potentially important demographic differences—the CORES study is based exclusively on South American cohorts and is hence multiracial, and the ARO study on a European cohort which includes significant numbers of patients from Eastern Europe. Together 24 000 patients were studied which provides weight to their observational studies.
- 5 May 2011
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 26 (6) , 1764-1766
Open AccessCKD-MBD: comfort in the trough of the U
Two large historical cohort studies, Control of Renal Osteodystrophy in South America (CORES) and Analyzing Data, Recognizing Excellence and Optimizing Outcome (ARO), are published in this issue of Nephrology Dialysis Transplantation. Both describe associations between biochemical measures of chronic kidney disease–mineral bone disease (CKD–MBD) which add usefully to the body of evidence already published in this and related fields. Hitherto, studies of this type have, with the exception of those derived from the Dialysis Outcomes and Practice Patterns (DOPPS) study, reflected data acquired from large US-based populations receiving maintenance dialysis. In contrast, the studies under discussion here have utilized patient groups with potentially important demographic differences—the CORES study is based exclusively on South American cohorts and is hence multiracial, and the ARO study on a European cohort which includes significant numbers of patients from Eastern Europe. Together 24 000 patients were studied which provides weight to their observational studies.